Savant Capital LLC Has $3.46 Million Stock Holdings in Ingevity Co. (NYSE:NGVT)

Savant Capital LLC trimmed its position in shares of Ingevity Co. (NYSE:NGVT) by 1.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 84,993 shares of the company’s stock after selling 1,273 shares during the quarter. Savant Capital LLC’s holdings in Ingevity were worth $3,463,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. First Horizon Advisors Inc. lifted its stake in shares of Ingevity by 45.9% in the third quarter. First Horizon Advisors Inc. now owns 862 shares of the company’s stock worth $34,000 after acquiring an additional 271 shares during the period. KBC Group NV lifted its stake in shares of Ingevity by 50.8% in the third quarter. KBC Group NV now owns 1,574 shares of the company’s stock worth $61,000 after acquiring an additional 530 shares during the period. Blue Trust Inc. lifted its stake in Ingevity by 179.6% in the third quarter. Blue Trust Inc. now owns 2,505 shares of the company’s stock valued at $98,000 after buying an additional 1,609 shares during the period. nVerses Capital LLC acquired a new position in Ingevity in the third quarter valued at approximately $113,000. Finally, Nisa Investment Advisors LLC lifted its stake in Ingevity by 27.3% in the third quarter. Nisa Investment Advisors LLC now owns 3,880 shares of the company’s stock valued at $151,000 after buying an additional 831 shares during the period. 91.59% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, BMO Capital Markets boosted their price target on Ingevity from $40.00 to $47.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $52.17.

Ingevity Trading Up 2.4 %

NYSE NGVT opened at $45.44 on Wednesday. The company has a market cap of $1.65 billion, a price-to-earnings ratio of -2.93 and a beta of 1.64. Ingevity Co. has a 52 week low of $30.90 and a 52 week high of $56.29. The business has a 50 day moving average price of $43.53 and a 200-day moving average price of $40.90. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 6.52.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.